Frontiers in Medicine (Sep 2022)

Peptides derived from hookworm anti-inflammatory proteins suppress inducible colitis in mice and inflammatory cytokine production by human cells

  • Claudia Cobos,
  • Paramjit S. Bansal,
  • David T. Wilson,
  • Linda Jones,
  • Guangzu Zhao,
  • Matthew A. Field,
  • Matthew A. Field,
  • Matthew A. Field,
  • Ramon M. Eichenberger,
  • Darren A. Pickering,
  • Rachael Y. M. Ryan,
  • Champa N. Ratnatunga,
  • John J. Miles,
  • Roland Ruscher,
  • Paul R. Giacomin,
  • Severine Navarro,
  • Severine Navarro,
  • Severine Navarro,
  • Alex Loukas,
  • Norelle L. Daly

DOI
https://doi.org/10.3389/fmed.2022.934852
Journal volume & issue
Vol. 9

Abstract

Read online

A decline in the prevalence of parasites such as hookworms appears to be correlated with the rise in non-communicable inflammatory conditions in people from high- and middle-income countries. This correlation has led to studies that have identified proteins produced by hookworms that can suppress inflammatory bowel disease (IBD) and asthma in animal models. Hookworms secrete a family of abundant netrin-domain containing proteins referred to as AIPs (Anti-Inflammatory Proteins), but there is no information on the structure-function relationships. Here we have applied a downsizing approach to the hookworm AIPs to derive peptides of 20 residues or less, some of which display anti-inflammatory effects when co-cultured with human peripheral blood mononuclear cells and oral therapeutic activity in a chemically induced mouse model of acute colitis. Our results indicate that a conserved helical region is responsible, at least in part, for the anti-inflammatory effects. This helical region has potential in the design of improved leads for treating IBD and possibly other inflammatory conditions.

Keywords